Clinical trial
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
NCT00294476 · GammaCan, Industry · Unknown status
Key facts
| NCT number | NCT00294476 |
|---|---|
| Title | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma |
| Official title | A One Arm, Open Label,Multi - Center Phase II Study to Evaluate the Safety and Efficacy of IVIG in the Treatment of Various Metastatic Solid Tumors for Which There is no Better Alternate Treatment |
| Lead sponsor | GammaCan, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer of Colon, Malignant Melanoma, Urologic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | IVIG, Biological Therapy |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| First posted | Feb 22, 2006 |
| Last update posted | Oct 12, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: